Chicago, IL (PRWEB) February 17, 2014
The prescription drug resource center at DrugNews.net is announcing new information on the site for patients taking the testosterone therapy drug AndroGel. Recent lawsuits allege men taking the low-T drug suffered heart attack or stroke without warning*.
DrugNews is a free resource providing the latest news, safety alerts, product recalls and litigation updates for patients taking popular prescription drugs. Visitors can see if others are experiencing similar side effects, avoid potential dangers and decide if they need legal advice.
Last year, more than 5.5 million men filled prescriptions for low-T drugs like AndroGel, Axiron and AndroDerm as the testosterone replacement industry grew over 500% in a decade**. However, recent studies question their safety.
DrugNews recently added a study from the National Institutes of Health and UCLA finding men aged 65 and older and those with a history of heart disease had double the risk of heart attack after starting testosterone therapy***.
A study published in November by the AMA also found older men or those with prior heart disease using the drugs had a 29% increased rate of heart attacks, stroke or death****.
Last month, the FDA launched an investigation into stroke, heart attack and death risks for testosterone therapy drugs based on the new findings*****.
Now, DrugNews has learned that at least two men have already filed lawsuits in a federal court alleging AndroGel caused heart attack or stroke without warning from the manufacturer*. Lawyers are offering help to those affected.
Anyone who suffered a heart attack, stroke or cardiovascular event after using AndroGel, Axiron or AndroDerm is urged to visit DrugNews or speak with a lawyer about their legal rights as soon as possible. DrugNews only recommends lawyers who have already handled defective drug lawsuits.
For more information on the research, side effects and litigation news related to testosterone drugs, or to speak with a lawyer, visit http://www.DrugNews.net.
*Bloomberg, 2/5/14; bloomberg.com/news/2014-02-05/abbott-labs-sued-by-five-men-claiming-androgel-injuries.html; Aurecchia v. AbbVie Inc., 14-cv-00772, U.S. Dist. Ct, Northern District of Illinois (Chicago); Marino v. AbbVie Inc., 14-cv-00777 U.S. Dist. Ct, Northern District of Illinois (Chicago)
**Bloomberg, 1/31/14; bloomberg.com/news/2014-01-31/heart-attack-risk-of-testosterone-drugs-under-u-s-review.html
***Public Library of Science, 1/29/14; plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0085805
****JAMA 11/5/13; media.jamanetwork.com/news-item/testosterone-therapy-following-coronary-angiography-associated-increased-risk-adverse-outcomes/